Thornburg Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-33,780
Closed -$11M 199
2024
Q1
$11M Sell
33,780
-4,114
-11% -$1.01M 0.15% 106
2023
Q4
$7.22M Buy
37,894
+1,321
+4% +$250K 0.1% 124
2023
Q3
$7.28M Sell
36,573
-957
-3% -$226K 0.12% 116
2023
Q2
$10.7M Sell
37,530
-6,427
-15% -$1.78M 0.17% 95
2023
Q1
$9.53M Buy
43,957
+5,196
+13% +$1.01M 0.16% 102
2022
Q4
$7.97M Sell
38,761
-1,895
-5% -$479K 0.13% 114
2022
Q3
$11.3M Sell
40,656
-8,155
-17% -$2.07M 0.2% 88
2022
Q2
$9.33M Sell
48,811
-2,137
-4% -$377K 0.14% 116
2022
Q1
$10.6M Sell
50,948
-5,788
-10% -$954K 0.14% 119
2021
Q4
$10.1M Buy
+56,736
New +$11.2M 0.12% 134

Other funds holding SWAV

Thornburg Investment Management's SWAV Position: Q2 2024 in Review

Thornburg Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 33,780 shares — an estimated $11M sold.

Thornburg Investment Management first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $11.3M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Thornburg Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Thornburg Investment Management sold 33,780 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $11M.
  • Thornburg Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Thornburg Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $11.3M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Thornburg Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.